PRODUCT DETAILS

About Euvifol-HP 150IU Injection

UROFOLLITROPIN belongs to the class of drugs called hormones used in the treatment of female infertility in women whose ovaries do not produce eggs and in women receiving treatments like IVF (in-vitro fertilization). Infertility is unable to become pregnant after trying for a year. Female infertility may be caused due to different factors affecting ovulation (release of egg from the ovary), fertilization (fusion of sperm and egg) and implantation (fertilized egg attaches to uterus lining).

Uses of Euvifol-HP 150IU Injection

Female infertility

Medicinal Benefits of Euvifol-HP 150IU Injection

UROFOLLITROPIN contains Urofollitropin that works similar to follicle-stimulating hormone (natural sex hormone). UROFOLLITROPIN increases oestrogen production that stimulates the development of the egg and mature follicle in women having ovulation (release of an egg from the ovary) problems and those undergoing IVF treatments.

Directions for Use

UROFOLLITROPIN is given as an injection under the skin (stomach or front of the thigh) by a doctor or nurse. Do not self-administer. If you are asked to take UROFOLLITROPIN by yourself, follow instructions given by your doctor.

Side Effects of Euvifol-HP 150IU Injection

• Headache
• Stomach pain
• Nausea
• Vomiting
• Pelvic pain
• Hot flushes (sudden feeling of warmth)
• Inflammation of throat and nasal passage

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

If you are allergic to UROFOLLITROPIN or any other medicines, please tell your doctor. If you have hyperprolactinemia (high levels of prolactin hormone), tumours of the pituitary gland, hypothalamus, uterus, breasts or ovaries, underactive adrenal or thyroid glands, blood clots, vaginal bleeding, uterus fibroids, early menopause, malformations of sexual organs, cysts on ovaries or enlarged ovaries, inform your doctor before taking UROFOLLITROPIN. Avoid taking UROFOLLITROPIN if you are pregnant or breastfeeding and consult a doctor before taking UROFOLLITROPIN. If you experience weight gain, stomach pain, diarrhoea, nausea, vomiting, difficulty in breathing, decreased urination or swelling in the stomach after few days of taking UROFOLLITROPIN last dose, please consult a doctor immediately as these might be signs of high levels of activity in the ovaries.

Drug Interactions

Drug-Drug Interaction:

UROFOLLITROPIN may interact with ovary stimulants (clomiphene citrate) and drugs used to prevent premature ovulation (ganirelix).

Drug-Disease Interaction:

If you have hyperprolactinemia (high levels of prolactin hormone), tumours of the pituitary gland, hypothalamus, uterus, breasts or ovaries, underactive adrenal or thyroid glands, vaginal bleeding, uterus fibroids, blood clots, early menopause, malformations of sexual organs, cysts on ovaries or enlarged ovaries, inform your doctor before taking UROFOLLITROPIN.

Safety Advice

ALCOHOL

Interaction of UROFOLLITROPIN with alcohol is unknown. Please consult a doctor before consuming alcohol while using UROFOLLITROPIN.

PREGNANCY

UROFOLLITROPIN is a category X pregnancy drug and is not recommended for use during pregnancy as it may cause multiple pregnancy (twins, triplets, etc.) and increase the risk of miscarriage, tubal pregnancy, birth defects or premature labour. However, please consult a doctor if you are pregnant.

BREAST FEEDING

UROFOLLITROPIN is contraindicated in breastfeeding women. It is unknown whether UROFOLLITROPIN is excreted in human milk. Therefore, please consult a doctor if you are breastfeeding.

DRIVING

UROFOLLITROPIN usually does not affect your ability to drive or operate machinery.

LIVER

If you have any concerns regarding the use of UROFOLLITROPIN in patients with Liver problems, please consult a doctor.

KIDNEY

If you have any concerns regarding the use of UROFOLLITROPIN in patients with kidney problems, please consult a doctor.